Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma
Clinical trial NCT01501942 · COMPLETED
Trial details
- NCT number
- NCT01501942
- Sponsor
- AIM Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-02-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.